CYP2A6, MAOA, DBH, DRD4, and 5HT2A genotypes, smoking behaviour and cotinine levels in 1518 UK adolescents
Authors:
- Derek G. CookDCDerek G. Cook
- Lesley J. HinksLHLesley J. Hinks
- Xiao-He ChenXCXiao-He Chen
- Shu YeSYShu Ye
- Julie A. GilgJGJulie A. Gilg
- Martin J. JarvisMJMartin J. Jarvis
- Peter H. WhincupPWPeter H. Whincup
- Ian N.M. DayIDIan N.M. Day
- 1 December 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Pharmacogenetics and Genomics
- Vol. 15 (12) , 839-850
Abstract
Smoking is a major cause of death and often initiates in adolescence. Mutations in CYP2A6 slow metabolism of nicotine to cotinine. Haploinsufficiency in adults is associated with lower cigarette consumption, lower cotinine level and higher quit rates. Other genes are also implicated in smoking behaviour. We explored smoking behaviour and cotinine levels in relation to genotypes in adolescents. 1518 subjects from the Ten Towns Heart Health Study were genotyped for CYP2A6 alleles *1A, *1B, *2, *4, *5, *9 and *12 to classify predicted nicotine metabolism rate. DBH(rs77905), MAOA(rs1801291+VNTR), DRD4(VNTR) and 5HT2A(rs6313) were also studied. Smoking status was established by questionnaire and salivary cotinine measurement at 13–15 and 18 years. No significant associations were identified for DBH, MAOA, DRD4 and 5HT2A markers, with smoking status or cotinine level at either age. At age 18, haploinsufficiency (HI) for CYP2A6 was associated with a higher odds of being a current smoker compared with the *1B carriers (WT1B) (OR=2.23 (1.16, 4.27) for current versus ex); *1A homozygotes (WT1A) were also at slightly higher risk (OR=1.44 (1.01, 2.06)). Partial haploinsufficiency (PHI) was not associated with being a current smoker. There were no significant associations at age 13–15. PHI and HI were associated with higher cotinine levels amongst smokers at both 13–15 and at 18 years compared with WT1B and WT1A groups. CYP2A6 haploinsufficiency increases likelihood of continuing smoking in teenagers. We hypothesize an explanatory ‘occupancy’ model to explain why haploinsufficiency results in faster progression to nicotine dependence, but lower subsequent consumption.Keywords
This publication has 45 references indexed in Scilit:
- Association of CYP2A6*1B genetic variant with the amount of smoking in French adults from the Stanislas cohortThe Pharmacogenomics Journal, 2005
- Genetically decreasedCYP2A6and the risk of tobacco dependence: a prospective study of novice smokersTobacco Control, 2004
- CYP2A6 genetic polymorphisms and correlation with smoking status in BraziliansThe Pharmacogenomics Journal, 2004
- Polymorphism of 5HT2A serotonin receptor gene is implicated in smoking addictionAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2004
- The problem of tobacco smokingBMJ, 2004
- Effects of dopamine receptor D4 variation on alcohol and tobacco use and on novelty seeking: Multivariate linkage and association analysisAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2003
- Characterization of a novelCYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activityHuman Mutation, 2002
- The DRD4 VNTR polymorphism influences reactivity to smoking cues.Journal of Abnormal Psychology, 2002
- Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolismFEBS Letters, 1999
- Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty SeekingNature Genetics, 1996